Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

  1. O’Shaughnessy, J.
  2. Brufsky, A.
  3. Rugo, H.S.
  4. Tolaney, S.M.
  5. Punie, K.
  6. Sardesai, S.
  7. Hamilton, E.
  8. Loirat, D.
  9. Traina, T.
  10. Leon-Ferre, R.
  11. Hurvitz, S.A.
  12. Kalinsky, K.
  13. Bardia, A.
  14. Henry, S.
  15. Mayer, I.
  16. Zhu, Y.
  17. Phan, S.
  18. Cortés, J.
Revue:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Année de publication: 2022

Volumen: 195

Número: 2

Pages: 127-139

Type: Article

DOI: 10.1007/S10549-022-06602-7 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus